Table 1.
Currently available biologics for T2 asthma
Drug | Mechanism | Route |
Omalizumab | Anti-IgE | Subcutaneous |
Mepolizumab | Anti-IL-5 | Subcutaneous |
Reslizumab | Anti-IL-5 | Intravenous |
Benralizumab | Anti-IL-5Rα | Subcutaneous |
Dupilumab | Anti-IL-4Rα | Subcutaneous |
R: receptor.